The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
about
Mechanism of Action and Applications of Interleukin 24 in ImmunotherapyTargeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinomaTrial Watch:: Oncolytic viruses for cancer therapyTrial Watch-Oncolytic viruses and cancer therapyA first-generation multi-functional cytokine for simultaneous optical tracking and tumor therapyPotent and specific antitumor effect for colorectal cancer by CEA and Rb double regulated oncolytic adenovirus harboring ST13 gene.Classification of current anticancer immunotherapiesmda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity.Complete eradication of xenograft hepatoma by oncolytic adenovirus ZD55 harboring TRAIL-IETD-Smac gene with broad antitumor effectRGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cellsTargeting gene-virotherapy of cancer and its prosperity.The Excellent Anti-Tumour Strategy (CTGVT, OV-gene) and the Excellent Anti-Tumor Gene (IL-24)Trial watch: Oncolytic viruses for cancer therapyA new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effectArmed replicating adenoviruses for cancer virotherapy."Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.Oncolytic adenoviruses expressing interleukin: a novel antitumour approach.Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy.Armed therapeutic viruses - a disruptive therapy on the horizon of cancer immunotherapy.Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.A conditionally replicating adenovirus expressing IL-24 acts synergistically with temozolomide to enhance apoptosis in melanoma cells in vitro.Enhanced antitumor effect of combining TRAIL and MnSOD mediated by CEA-controlled oncolytic adenovirus in lung cancer.Targeting eradication of chronic myeloid leukemia using chimeric oncolytic adenovirus to drive IL-24 expression.Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model.A conditionally replicating adenovirus carrying interleukin-24 sensitizes melanoma cells to radiotherapy via apoptosis.A novel conditionally replicating adenoviral vector with dual expression of IL-24 and arresten inserted in E1 and the region between E4 and fiber for improved melanoma therapy.Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.Killing of human melanoma cells induced by activation of class I interferon-regulated signaling pathways via MDA-7/IL-24.Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis.Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo.Combining virotherapy and angiotherapy for the treatment of breast cancer.Combination of oncolytic adenovirus and luteolin exerts synergistic antitumor effects in colorectal cancer cells and a mouse model.Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis.
P2860
Q26748450-82700FEC-9C5B-4444-9BD7-CB9DBF0701A3Q26772315-373EA902-E5BC-4BCF-8AE4-1B937E34BF7EQ27021951-7D03FE48-0E10-4B00-9B5D-D7697A71186FQ28072347-C749840F-E7D6-4680-B058-A7B4A2B33C8BQ34341900-3E38FF0B-E735-42E0-AE45-BF3BE5688E59Q34450950-95003F91-E857-4551-B823-57871A2717BBQ35149637-BEECDD40-C4A9-418D-AD13-AA739A8736FDQ35189796-F6CD8FEC-87CF-4DA3-A03E-1694055553BEQ36228905-B6F1E876-21E6-42BC-8072-279ABA4B31FCQ36346959-911C81E3-CBA2-44E3-B7B3-A81B29F80BDCQ36653149-A15ADA7E-EC62-4C50-8084-C1DA1B3B897CQ36735750-6018E1E8-5CAF-443F-8A2C-17F98DDC66A2Q37028023-5D51F845-135C-464F-B86B-8037112900C7Q37295187-303BCAAD-7CA8-421B-92F4-E807C63B5594Q37386616-5CCC3BE4-5A19-4150-A63D-173D4E98619BQ37622288-B41F5A13-CE32-4EE4-878B-99A6DAE6CF74Q37733550-C37FCF0E-1E84-4A33-9F8E-21B43D8793E7Q37945288-724B26CA-2D90-4D8A-8C39-2E363FF02E48Q38194135-39B4BDC1-940A-403B-B77B-C2F534B0C1CEQ38223419-84ABBAD2-F061-4CC4-8C41-76C6CBD30F48Q38733784-41B1E896-B420-456E-97C3-369CE8CFDD18Q38778137-7D1F9EEF-0597-4F5E-BD94-43EA4012B684Q38861342-C69B2E96-9995-4D2D-9539-63E3D87DBB40Q39215780-C976014B-CC51-46B6-8B93-8C14E57A4E36Q39336014-305C6014-A0DF-45C9-8564-EE335E575C9CQ39423631-F486B492-DC8A-4037-B7BC-34A07ACC5A66Q39462019-58311020-87AE-4674-BBEB-415A877C61F6Q39552139-2CD44199-B13E-4313-A5A8-A2D93A6668D4Q39575065-32F54E56-F85A-4CF5-86CA-64A8BAEF0EAAQ39977288-4D703E03-D695-4150-9FC2-EA0769C6BB25Q40043099-9C2FDE76-4521-46F7-A7BC-25D383252728Q42201282-73CC08F5-CC47-49D0-8A3C-0AB5F5160189Q42284431-ACD85313-0FD8-42B8-AEB8-A53C493A47D1Q47609998-7B8ED751-88C8-41B0-B7EF-E2D1A0C99663Q48102914-795901DA-E26E-4930-A775-52758774F1A6
P2860
The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The antitumor activity of TRAI ...... enovirus in colorectal cancer.
@en
type
label
The antitumor activity of TRAI ...... enovirus in colorectal cancer.
@en
prefLabel
The antitumor activity of TRAI ...... enovirus in colorectal cancer.
@en
P2093
P2860
P921
P356
P1433
P1476
The antitumor activity of TRAI ...... enovirus in colorectal cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.CGT.7700969
P577
2006-06-23T00:00:00Z
P5875
P6179
1022964924